Last reviewed · How we verify

NCT06579807

Cardiac Rehabilitation and Coronary Artery Disease

Recruiting now NA Last updated 27 March 2026
What this trial tests

NA trial testing Exercise training in Coronary Artery Disease in 50 participants. Currently enrolling.

Timeline
1 October 2024
Primary endpoint
31 December 2026
31 December 2026

Quick facts

Lead sponsorInstituto Nacional de Cardiologia de Laranjeiras
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingsingle
Primary purposesupportive care
Enrollment50
Start date1 October 2024
Primary completion31 December 2026
Estimated completion31 December 2026
Sites1 location across Brazil

Drugs / interventions tested

Conditions studied

Sponsor

Instituto Nacional de Cardiologia de Laranjeiras

Who can join

Adults 40 to 70, any sex, with Coronary Artery Disease or Atherosclerosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Patients with coronary artery disease (CAD) aged 40-70 years will undergo exercise training (thrice weekly for 12 weeks). A reference group composed of healthy individuals will be included. Evaluations will be conducted at baseline and after the intervention period during two visits. During the first visit, carotid artery thickness will be assessed via ultrasound before and after a cardiopulmonary exercise testing. The second visit will include the evaluation of endothelial function using venous occlusion plethysmography. After this, participants will engage in 30 minutes of moderate-intensity aerobic exercise, and blood samples will be collected pre- and post-exercise. Circulating levels of kynurenine pathway (KP) metabolites (Tryptophan, kynurenine, kynurenic acid, and quinolinic acid), pro-inflammatory cytokines, cell adhesion molecules, and lipid profiles will be measured via Enzyme-Linked Immunosorbent Assay (ELISA), multiplex essays, and biochemical analysis; respectively.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Acute and chronic effects of physical exercise on atherosclerosis, kynurenine pathway, endothelial function and inflammation in patients with coronary artery disease: a clinical trial protocol.
    Paz GA, Rangel MV, Farias CL, Soares ALC, et al · · 2025 · cited 3× · PMID 39944998 · DOI 10.1136/bmjsem-2024-002432
  2. Kynurenine as a Predictor of Long-Term Mortality: A 10-Year Follow-Up from the KORONEF Registry.
    Kern A, Stompór T, Bojko K, Sienkiewicz E, et al · · 2025 · cited 1× · PMID 40426950 · DOI 10.3390/biomedicines13051123

Verify or expand the search:

Other trials of Exercise training

Trials testing the same drug.

Other recruiting trials for Coronary Artery Disease

Currently open trials in the same condition.

Other Instituto Nacional de Cardiologia de Laranjeiras trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06579807.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing